Dan Weng
Clinical Research
Ergomed
India
Biography
Dr Weng joined Ergomed as CEO in July 2017 after six years at EPS International Holding Co., where he was Chairman, President and CEO. During his tenure, Dan oversaw significant growth, both organically and through M&A in Asia, the US and Europe, with revenues increasing over five-fold. He was also a Board Director of EPS Holdings, Inc., a global CRO listed on the Tokyo Stock Exchange
Research Interest
Clinical Research
